➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Boehringer Ingelheim
Express Scripts
Dow
Baxter

Last Updated: August 11, 2020

DrugPatentWatch Database Preview

Pancuronium bromide - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for pancuronium bromide and what is the scope of freedom to operate?

Pancuronium bromide is the generic ingredient in two branded drugs marketed by Dr Reddys, Elkins Sinn, Hospira, Igi Labs Inc, and Organon Usa Inc, and is included in twelve NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for pancuronium bromide. One supplier is listed for this compound.

Summary for pancuronium bromide
Pharmacology for pancuronium bromide
Medical Subject Heading (MeSH) Categories for pancuronium bromide

US Patents and Regulatory Information for pancuronium bromide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Organon Usa Inc PAVULON pancuronium bromide INJECTABLE;INJECTION 017015-001 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
Igi Labs Inc PANCURONIUM BROMIDE pancuronium bromide INJECTABLE;INJECTION 072211-001 Mar 31, 1988 DISCN No No   Start Trial   Start Trial   Start Trial
Elkins Sinn PANCURONIUM BROMIDE pancuronium bromide INJECTABLE;INJECTION 072060-001 Mar 23, 1988 DISCN No No   Start Trial   Start Trial   Start Trial
Hospira PANCURONIUM BROMIDE pancuronium bromide INJECTABLE;INJECTION 072321-001 Jan 19, 1989 DISCN No No   Start Trial   Start Trial   Start Trial
Igi Labs Inc PANCURONIUM BROMIDE pancuronium bromide INJECTABLE;INJECTION 072210-001 Mar 31, 1988 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for pancuronium bromide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon Usa Inc PAVULON pancuronium bromide INJECTABLE;INJECTION 017015-002 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Organon Usa Inc PAVULON pancuronium bromide INJECTABLE;INJECTION 017015-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
Baxter
Express Scripts
Mallinckrodt
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.